Evogene · raw details

Computational Predictive Biology Platform · Rehovot · Founded 2002

active Public ← back to profile

Highlights

IIA supported (ever)1 patentProfile claimed by owner

About

Computational Predictive Biology Platform

Evogene is a computational biology company focused on revolutionizing product discovery and development in multiple life sciences-based industries, including human health and agriculture, through the use of its broadly applicable computational predictive biology (CPB) platform.

The CPB platform, incorporating a deep understanding of biology leveraged through the power of big data and artificial intelligence, has been designed to computationally discover and guide the development of life sciences products based on microbes, small molecules, and genetic elements.

Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd, medical cannabis through Canonic Ltd, agricultural biologicals through Lavie Bio Ltd, agriculture chemicals through AgPlenus Ltd, and agriculture solutions for castor oil production through Castera Ltd.

Identity

NameEvogene
Slugevogene
Type / kindstartup
Crunchbase IDevogene
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6ZsbcKDA

Status

Statusactive
Status reasonPublic on TASE on Jun, 2007;Public on NASDAQ on Nov, 2013;
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityRehovot
HQ address13 Derech Gad Feinstein, Rehovot, Israel

Web & social

Websitehttps://evogene.com
Careers pagehttp://evogene.com/careers
LinkedInhttps://www.linkedin.com/company/100603
Facebookhttps://www.facebook.com/evogene123

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Climate TechFood & Land UseSustainable FarmingAgriculture & Food TechnologiesAg TechGenetics & InputHealth Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceBiologicalsGenes
Target customers
Agriculture & FoodHealthcare & Life SciencesLife SciencesPharmaceuticalsIndustrial Manufacturing
Business models
B2B
Tags
sustainable-farmingcropsbiotechnologyplant-genomicsagtechbreedingbig-databiofuelclimate-techgenomicschemicalsartificial-intelligencegeneticsseedspharmaceuticals

Funding

Total raised$135.7M
Current stagePublic
Market cap$9.3M

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}